Spectral medical inc. closes c$6.1 million bought deal convertible note financing

Tigris patient enrollment momentum continues reaching 72 the company anticipates three additional trial sites to be activated in q3 not for distribution to united states newswire services or for dissemination in the united states toronto, sept. 07, 2023 (globe newswire) -- spectral medical inc. (tsx: edt) (“spectral” or the “company”) is pleased to announce that it has closed its previously announced ”bought deal” private placement of 9.0% convertible unsecured senior notes due november 1, 2026 (the “notes") of the company at a price of us$1,000 per note (the “issue price”) for aggregate gross proceeds of us$4,553,000 (the "offering").
BAX Ratings Summary
BAX Quant Ranking